I didn't mean that the CC would be delayed. Just any serious news. The market has not approved of our latest conferences and worry there might be hesitation and a lack of understanding with the information provided on the call. Hence a sell off. To many people go into these calls hoping for the moon.
If revenue guidance isn't given in a clear and precise manner, the bashers and flippers who love to scare the masses will beat the sell drums.
Hopefully the team is putting a call together that will detail our timeline and answer questions about LYMPRO and PHENO that will quiet the doubters.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links